Microarray analysis of gene expression associated with extrapulmonary dissemination of tuberculosis

Respirology

Volumn 11, Issue 5, 2006, Pages 557-565

  Kim, Deog Kyeom ^a   Park, Geun Min ^a   Hwang, Yong Il ^a   Kim, Hyun Ji ^a   Han, Sung Koo ^a   Shim, Young Soo ^a   Yim, Jae Joon ^a  

^a Seoul National University College of Medicine   (South Korea)

Author keywords

Cathepsin W; Microarray; Tuberculosis; Tumour necrosis factor ; Tumour necrosis factor receptor superfamily member 7

Indexed keywords

CATHEPSIN; CATHEPSIN W; RNA; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ADULT; AGED; ANALYTIC METHOD; ARTICLE; CELL LYSATE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; EXTRAPULMONARY TUBERCULOSIS; GENE; GENE EXPRESSION; HEREDITY; HUMAN; INCUBATION TIME; MALE; MICROARRAY ANALYSIS; MYCOBACTERIUM TUBERCULOSIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; AGED; ANTIGENS, CD27; CATHEPSIN W; CATHEPSINS; CYSTEINE ENDOPEPTIDASES; GENE EXPRESSION PROFILING; HUMANS; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUBERCULOSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33746901578     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2006.00896.x     Document Type: Article

References (50)

1. Rieder HL, Snider DE Jr, Cauthen GM. Extrapulmonary tuberculosis in the United States. Am. Rev. Respir. Dis. 1990; 141: 347-51.
2. Cowie RL, Sharpe JW. Extra-pulmonary tuberculosis: a high frequency in the absence of HIV infection. Int. J. Tuberc. Lung Dis. 1997; 1: 159-62.
3. Huang J, Shen M, Sun Y. [Epidemiological analysis of extrapulmonary tuberculosis in Shanghai.] Zhonghua Jie He He Hu Xi Za Zhi 2000; 23: 606-8.
4. US Department of Health and Human Services. Tuberculosis Statistics in the United States, 1990. US Department of Health and Human Services, Atlanta, 1992.
5. Kent SJ, Crowe SM, Yung A et al. Tuberculous meningitis: a 30-year review. Clin. Infect. Dis. 1993; 17: 987-94.
6. Ramachandran P, Duraipandian M, Reetha AM et al. Long-term status of children treated for tuberculous meningitis in south India. Tubercle 1989; 70: 235-9.
7. Kim JH, Langston AA, Gallis HA. Miliary tuberculosis: epidemiology, clinical manifestations, diagnosis, and outcome. Rev. Infect. Dis. 1990; 12: 583-90.
8. Maartens G, Willcox PA, Benatar SR. Miliary tuberculosis: rapid diagnosis, hematologic abnormalities, and outcome in 109 treated adults. Am. J. Med. 1990; 89: 291-6.
9. Mert A, Bilir M, Tabak F et al. Miliary tuberculosis: clinical manifestations, diagnosis and outcome in 38 adults. Respirology 2001; 6: 217-24.
10. Kim JY, Park YB, Kim YS et al. Miliary tuberculosis and acute respiratory distress syndrome. Int. J. Tuberc. Lung Dis. 2003; 7: 359-64.
11. Bellamy R, Ruwende C, Corrah T et al. Variations in the NRAMP1 gene and susceptibility to tuberculosis in West Africans. N. Engl. J. Med. 1998; 338: 640-4.
12. Gao PS, Fujishima S, Mao XQ et al. Genetic variants of NRAMP1 and active tuberculosis in Japanese populations. International Tuberculosis Genetics Team. Clin. Genet. 2000; 58: 74-6.
13. Cervino AC, Lakiss S, Sow O et al. Allelic association between the NRAMP1 gene and susceptibility to tuberculosis in Guinea-Conakry. Ann. Hum. Genet. 2000; 64: 507-12.
14. Ryu S, Park YK, Bai GH et al. 3'UTR polymorphisms in the NRAMP1 gene are associated with susceptibility to tuberculosis in Koreans. Int. J. Tuberc. Lung Dis. 2000; 4: 577-80.
15. Liaw YS, Tsai-Wu JJ, Wu CH et al. Variations in the NRAMP1 gene and susceptibility of tuberculosis in Taiwanese. Int. J. Tuberc. Lung Dis. 2002; 6: 454-60.
16. Bellamy R, Ruwende C, Corrah T et al. Tuberculosis and chronic hepatitis B virus infection in Africans and variation in the vitamin D receptor gene. J. Infect. Dis. 1999; 179: 721-4.
17. Wilkinson RJ, Llewelyn M, Toossi Z et al. Influence of vitamin D deficiency and vitamin D receptor polymorphisms on tuberculosis among Gujarati Asians in west London: a case-control study. Lancet 2000; 355: 618-21.
18. Wilkinson RJ, Patel P, Llewelyn M et al. Influence of polymorphism in the genes for the interleukin (IL)-1 receptor antagonist and IL-1beta on tuberculosis. J. Exp. Med. 1999; 189: 1863-74.
19. Bellamy R, Ruwende C, Corrah T et al. Assessment of the interleukin 1 gene cluster and other candidate gene polymorphisms in host susceptibility to tuberculosis. Tuber. Lung Dis. 1998; 79: 83-9.
20. Selvaraj P, Sriram U, Mathan Kurian S et al. Tumour necrosis factor alpha (-238 and -308) and beta gene polymorphisms in pulmonary tuberculosis: haplotype analysis with HLA-A, B and DR genes. Tuberculosis (Edinb) 2001; 81: 335-41.
21. Akahoshi M, Nakashima H, Miyake K et al. Influence of interleukin-12 receptor beta1 polymorphisms on tuberculosis. Hum. Genet. 2003; 112: 237-43.
22. Remus N, El Baghdadi J, Fieschi C et al. Association of IL12RB1 polymorphisms with pulmonary tuberculosis in adults in Morocco. J. Infect. Dis. 2004; 190: 580-7.
23. Brown PO, Botstein D. Exploring the new world of the genome with DNA microarrays. Nat. Genet. 1999; 21: 33-7.
24. Alizadeh AA, Eisen MB, Davis RE et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000; 403: 503-11.
25. van't Veer LJ, Dai H, van de Vijver MJ et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002; 415: 530-6.
26. Pethe K, Alonso S, Biet F et al. The heparin-binding haemagglutinin of M. tuberculosis is required for extrapulmonary dissemination. Nature 2001; 412: 190-4.
27. Al-Arif LI, Goldstein RA, Affronti LF et al. HLA-Bw15 and tuberculosis in a North American black population. Am. Rev. Respir. Dis. 1979; 120: 1275-8.
28. Barnes PF, Abrams JS, Lu S et al. Patterns of cytokine production by mycobacterium-reactive human T-cell clones. Infect. Immun. 1993; 61: 197-203.
29. Serbina NV, Flynn JL. Early emergence of CD8(+) T cells primed for production of type 1 cytokines in the lungs of Mycobacterium tuberculosis-infected mice. Infect. Immun. 1999; 67: 3980-8.
30. Flynn JL, Goldstein MM, Chan J et al. Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity 1995; 2: 561-72.
31. Bean AG, Roach DR, Briscoe H et al. Structural deficiencies in granuloma formation in TNF gene-targeted mice underlie the heightened susceptibility to aerosol Mycobacterium tuberculosis infection, which is not compensated for by lymphotoxin. J. Immunol. 1999; 162: 3504-11.
32. Kindler V, Sappino AP, Grau GE et al. The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection. Cell 1989; 56: 731-40.
33. Ehlers S, Benini J, Kutsch S et al. Fatal granuloma necrosis without exacerbated mycobacterial growth in tumor necrosis factor receptor p55 gene-deficient mice intravenously infected with Mycobacterium avium. Infect. Immun. 1999; 67: 3571-9.
34. Keane J, Gershon S, Wise RP et al. Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N. Engl. J. Med. 2001; 345: 1098-104.
35. Mohan AK, Cote TR, Block JA et al. Tuberculosis following the use of etanercept, a tumor necrosis factor inhibitor. Clin. Infect. Dis. 2004; 39: 295-9.
36. Engele M, Stossel E, Castiglione K et al. Induction of TNF in human alveolar macrophages as a potential evasion mechanism of virulent Mycobacterium tuberculosis. J. Immunol. 2002; 168: 1328-37.
37. Bekker LG, Maartens G, Steyn L et al. Selective increase in plasma tumor necrosis factor-alpha and concomitant clinical deterioration after initiating therapy in patients with severe tuberculosis. J. Infect. Dis. 1998; 178: 580-4.
38. Brown J, Matutes E, Singleton A et al. Lymphopain, a cytotoxic T and natural killer cell-associated cysteine proteinase. Leukemia 1998; 12: 1771-81.
39. Linnevers C, Smeekens SP, Bromme D. Human cathepsin W, a putative cysteine protease predominantly expressed in CD8+ T-lymphocytes. FEBS Lett. 1997; 405: 253-9.
40. Wex T, Buhling F, Wex H et al. Human cathepsin W, a cysteine protease predominantly expressed in NK cells, is mainly localized in the endoplasmic reticulum. J. Immunol. 2001; 167: 2172-8.
41. Flynn JL, Chan J. Immunology of tuberculosis. Annu. Rev. Immunol. 2001; 19: 93-129.
42. Camerini D, Walz G, Loenen WA et al. The T cell activation antigen CD27 is a member of the nerve growth factor/tumor necrosis factor receptor gene family. J. Immunol. 1991; 147: 3165-9.
43. Hendriks J, Gravestein LA, Tesselaar K et al. CD27 is required for generation and long-term maintenance of T cell immunity. Nat. Immunol. 2000; 1: 433-40.
44. Arens R, Nolte MA, Tesselaar K et al. Signaling through CD70 regulates B cell activation and IgG production. J. Immunol. 2004; 173: 3901-8.
45. Hirano T, Yonekubo I, Shimo K et al. CD27 synergizes with CD40 to induce IgM, IgG, and IgA antibody responses of peripheral blood B cells in the presence of IL-2 and IL-10. Immunol. Lett. 2003; 89: 251-7.
46. Jouanguy E, Lamhamedi-Cherradi S, Lammas D et al. A human IFNGR1 small deletion hotspot associated with dominant susceptibility to mycobacterial infection. Nat. Genet. 1999; 21: 370-8.
47. Altare F, Ensser A, Breiman A et al. Interleukin-12 receptor beta1 deficiency in a patient with abdominal tuberculosis. J. Infect. Dis. 2001; 184: 231-6.
48. Dorman SE, Picard C, Lammas D et al. Clinical features of dominant and recessive interferon gamma receptor 1 deficiencies. Lancet 2004; 364: 2113-21.
49. Holland SM. The interferons. In: Holland SM (ed.). Cytokine Therapeutics in Infectious Diseases. Lippincott Williams and Wilkins, Philadelphia, 2001; 221-50.
50. Park GY, Im YH, Ahn CH et al. Functional and genetic assessment of IFN-gamma receptor in patients with clinical tuberculosis. Int. J. Tuberc. Lung Dis. 2004; 8: 1221-7.